Towns --- a steady step into the microbiome market, capital business partnership with KINS.
Towns <197A>, one of the largest companies in infectious disease POCT (Point of Care Testing: simple rapid testing systems), manufactures in vitro diagnostic Pharmaceuticals and research reagents utilizing various diagnostic technologies, selling them domestically and internationally, has announced a capital and business alliance with KINS. The company is steadily advancing towards its goal of entering the chronic disease field, which it has been pursuing for some time. KINS is expected to generate early sales in its consumer Health Care business and clinic operations.
TAUNS Laboratories Takes 10.7% Stake in AI Diagnostic Startup Aillis
<Today's individual items> Towns, Mizukou, Aeon, Tsuruha HD, ETC (announced on the 4th)
▽ Towns <197A.T> has partnered with Iris (Chuo-ku, Tokyo), which is engaged in the development and manufacturing of Medical Devices using AI technology. ▽ ZuiKou <6279.T> expects to turn profitable in the consolidated results for the fiscal year ending February 2026, with an annual Dividends increase to 16 yen (previous period's performance: 10 yen). ▽ AEON <8267.T> has revised its consolidated profit forecast downward for the fiscal year ending February 2025. ▽ Tsuruha HD <3391.T> has lowered its consolidated performance forecast for the fiscal year 2025 (from May 16, 2024 to February 28, 2025). ▽ Adas
Express News | [Change Report] Masataka Nonaka reported a decrease in the Shareholding ratio of Towns (197A.JP) to 30.33%.
Pay attention to Koshidaka HD and Topy Industries.
In yesterday's US stock market, the Dow Jones Industrial Average fell by $11.80 to 41,989.96, the Nasdaq Composite Index rose by 150.60 points to 17,449.89, and the Chicago Nikkei 225 Futures increased by 125 yen compared to the Osaka daytime market, reaching 35,745 yen. The exchange rate is 1 dollar = 149.50-60 yen. In today's Tokyo market, Kosidaka Holdings announced a business partnership with Pan Pacific International Holdings, and will report a gain from the sale of investment securities amounting to 2.371 billion yen as special income for the fourth quarter of the fiscal year ending March 2025.
Rating information (Target Price change - Part 2) = Sapporo HD, Kao, etc.
◎ Mizuho Securities (three-tiered: Buy > Hold > Underperform) Sapporo HD <2501.T> -- "Hold" → "Hold", 6700 yen → 6900 yen Furukawa Electric <5801.T> -- "Hold" → "Hold", 6500 yen → 6300 yen Sumitomo Electric <5802.T> -- "Hold" → "Hold", 3050 yen → 2880 yen ◎ Morgan Stanley MUFG Securities (three-tiered: Overweight > Equal Weight > Underweight) Kao <4452.T> -- "Overweight"
Sony Group Corp has revised its forecast upwards for March 25, with operating profit of 1 trillion 335 billion yen, up from 1 trillion 310 billion yen.
Sony Group Corp (6758) announced a revision of its Financial Estimates for the fiscal year ending March 2025. Revenue has been revised upwards from 12 trillion 710 billion yen to 13 trillion 200 billion yen, and operating profit from 1 trillion 310 billion yen to 1 trillion 335 billion yen. Entertainment-related segments such as Gaming and music are performing steadily. Additionally, it was announced that a share buyback program with a cap of 50 billion yen has been established, allowing the purchase of up to 30 million shares (0.5% of the total issued shares excluding treasury shares) in the market. 【Positive evaluation】<675
Tauns Laboratories Shows Strong Financial Performance for FY2025 First Half
Tauns Laboratories: Interim financial results presentation materials for the fiscal year ending 2025/6
Tauns Laboratories: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/6 [Japanese GAAP] (unconsolidated)
Tauns Laboratories: Half Year Report - Term 10 (2024/07/01 - 2025/06/30)
Tauns Laboratories: Confirmation
Towns has signed a business partnership agreement with ZACROS.
Towns <197A.T> announced on the 6th that it has signed a business alliance agreement with ZACROS <7917.T>. The company is working on the development of innovative diagnostic products aimed at the global market by utilizing ZACROS's biochip technology in its next-generation POC devices currently under development. This partnership is expected to enhance the functionality and expand the Range of the next-generation POC devices, while ZACROS anticipates significant adoption achievements in its biochip business. The closing price on the 6th was 593 yen, down 1 yen from the previous day.
TAUNS Laboratories, Zacros Form Alliance for Next-Gen Point-of-Care Testing Devices
January 29 [Today's Investment Strategy]
[Fisco Selected Stocks] 【Material Stocks】 FDK <6955> 693 yen (1/28) A Battery manufacturer under the Fujitsu brand. Also involved in modules and switching power supplies. Announced the third quarter financial results. Cumulative operating profit is 1.308 billion yen. The same period last year was 0.105 billion yen. The battery business saw revenue increases and profitability due to fluctuations in raw material prices. Furthermore, the effects of the weak yen were added. The operating profit for the fiscal year ending March 2025 is estimated to be 1.3 billion yen (2.2 times compared to the previous year). Up to the third quarter.
Tauns Laboratories Granted Patent for Advanced Detection Method
Attention is focused on Tokiko Takayama and Yamazaki Bread, while UBE and Chubu Steel Plate are showing soft trends.
In the US stock market on the 28th, the Dow Jones Industrial Average rose by 136.77 points to 44,850.35, the Nasdaq Composite Index increased by 391.76 points to 19,733.59, and the Chicago Nikkei 225 Futures was up by 340 yen compared to day time in Osaka at 39,410 yen. The exchange rate was 1 dollar = 155.50-60 yen. In today's Tokyo market, Shin-Etsu Polymer <7970> reported a 21.7% increase in cumulative operating profit for the third quarter, which is an expansion from a 17.7% increase in the first half, with the progress rate against the full-year Financial Estimates up to the third quarter.
Japanese Shares Rise as Markets Brace for BOJ Rate Hike
TAUNS Laboratories Signs Agreement With Roche Diagnostics
January 23 [Today's Investment Strategy]
[Fisco Selected Stocks] [Material Stocks] Gokurakuyu Holdings <2340> 470 yen (1/22) operates bath facilities under the "Gokurakuyu" and "RAKU SPA" brands. It was announced that a business partnership was formed with Hinata no Mori, a group company of Nishi Nihon Gas Holdings <9536>, which operates the bath facility "Hinata no Mori Kodo no Yudokoro". In addition to conducting promotional events organized by Gokurakuyu at "Hinata no Mori Kodo no Yudokoro", there will also be joint development of products and services related to the bathing business.